• BioCryst R&D Day Highlights New Diversified Pipeline of First-in-Class/Best-in-Class Therapies with Five Programs Expected in Clinical Development in Next 24 Months

    来源: Nasdaq GlobeNewswire / 03 11月 2023 11:03:00   America/Chicago

    N/A
分享